/Companies

Novo Nordisk

Copenhagen, DK · Founded 1923 · 62,246 employees on LinkedIn · 2 known investors

Find your way into Novo Nordisk

Sign up to see every warm intro you have to Novo Nordisk

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Novo Nordisk team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Novo Nordisk is a pharmaceutical company that develops and markets treatments for conditions including diabetes, obesity/weight management, and haemophilia, with products such as GLP-1 therapies. It serves patients and healthcare markets globally.

Founders & leadership

MMMaziar Mike Doustdar
Maziar Mike DoustdarPresident and CEOMaziar Mike Doustdar is CEO of Novo Nordisk, a pharmaceutical company developing treatments for diabetes, obesity, and other chronic diseases.

Investors · 2

24 people who came through Novo Nordisk went on to found or lead other companies.

+ 12 more →

Related companies · 3

Companies working in the same space as Novo Nordisk.

Acquisitions · 5

Early investors' stakes continue via these deals
Calibrium

Calibrium was an Indiana-based biopharmaceutical startup founded in 2013 that developed novel peptide and insulin-based drug candidates for diabetes and obesity.

Dicerna

Dicerna Pharmaceuticals was a biotechnology company developing RNA interference (RNAi) therapeutics for rare and genetic diseases and oncology using its GalXC platform.

Forma Therapeutics

Clinical-stage biopharmaceutical company focused on developing novel therapeutics for rare hematologic diseases and cancers, acquired by Novo Nordisk in 2022.

Inversago

Portfolio company acquired by Novo Nordisk for $1.1B USD.

KBP

Hypertension company acquired by Novo Nordisk.

Frequently asked questions

What does Novo Nordisk do?
Novo Nordisk is a pharmaceutical company that develops and markets treatments for conditions including diabetes, obesity/weight management, and haemophilia, with products such as GLP-1 therapies. It serves patients and healthcare markets globally.
Who are Novo Nordisk's investors?
Novo Nordisk's investors include HM Venture Partners, Novo Holdings.
Where is Novo Nordisk headquartered?
Novo Nordisk is headquartered in Copenhagen, DK.